Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children

Rocío Galindo-Zavala, Rosa Bou-Torrent, Berta Magallares-López et al

Pediatr Rheumatol Online J. 2020; 18: 20

https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-020-0411-9

 

EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency

Sabina Baumgartner-Parzer, Martina Witsch-Baumgartner, Wolfgang Hoeppner

Eur J Hum Genet. 2020 Oct; 28(10): 1341–1367

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609334/

 

Evolving pituitary hormone deficits in primarily isolated GHD: a review and expert´s consensus

Gerhard Binder, Dirk Schnabel, Thomas Reinehr et al

Mol Cell Pediatr. 2020 Dec; 7: 16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606365/

 

Genetic causes of hypopituitarism

Katherine Parkin, Ritika Kapoor, Ravindra Bhat, Anne Greenough

Arch Med Sci. 2020; 16(1): 27–33.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963153/

 

Newborn feeding recommendations and practices increase the risk of development of overweight and obesity

Brittany Watchmaker, Bridget Boyd, Lara R. Dugas

BMC Pediatr. 2020; 20: 104

https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-020-1982-9

 

Monitoring of pediatric type 1 diabetes

Brynn E. Marks, Joseph I. Wolfsdorf

Front Endocrinol (Lausanne) 2020; 11: 128

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089921/

 

Diagnosis and treatment of growth hormone deficiency: a position statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology

J H Kim, H W Chae, S O Chin et al

Endocrinol Metab (Seoul) 2020, vol 35 (2): 272-27

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386113/

 

Tratamiento con hormona de crecimiento en el síndrome de Noonan: revisión de la bibliografia y recomendaciones de tratamiento

A Carcavilla, L Suárez-Ortega, M Ramón-Krauel et al

Rev Esp Endocrinol Pediatr 2020, vol 11 (1): 23-39

https://www.endocrinologiapediatrica.org/modules.php?name=articulos&idarticulo=584&idlangart=ES

 

Diagnosis, genetics, and therapy of short stature in children: A Growth Hormone Research Society International Perspective

Paulo F. Collett-Solberg, Geoffrey Ambler, Philippe F. Backeljauw et al

Horm Res Paediatr. 2019 Dec; 92(1): 1–14

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979443/

 

Towards a rational and efficient diagnostic approach in children referred for tall stature and/or accelerated growth to the general paediatrician

P Lauffer, G A Kamp, L A Menke et al

On behalf of the Dutch Working Group on Triage and Diagnosis of Growthh Disorders in Children

Horm Res Paediatr 2019, vol 91: 293-310

https://www.karger.com/Article/FullText/500810

 

Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease

J Drube, M Wan, M Bonthuis et al

Eur Thyroid J 2019, vol 8: 227-245

On behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups

Nature Reviews Nephrology 2019, vol 15: 577-589

https://www.nature.com/articles/s41581-019-0161-4

 

Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings

Bradley S Miller, Sandra P Spencer, Mitchell E Geffner et al

J Investig Med. 2020 Jan; 68(1): 16–25.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996103/

 

Clinical practice guideline for the diagnosis and treatment of pediatric obesity: recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology Hepatology and Nutrition

Dae Yong Yi, Soon Chul Kim, Ji Hyuk Lee et al

Pediatr Gastroenterol Hepatol Nutr. 2019 Jan; 22(1): 1–27

https://www.e-cep.org/upload/pdf/kjp-2018-07360.pdf

 

Cardiovascular implications in idiopathic and syndromic obesity in childhood: an update

Maurizio Delvecchio, Carmela Pastore, Federica Valente, Paola Giordano

Front Endocrinol (Lausanne) 2020; 11: 330

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296059/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: Fevereiro 2021